Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion
Bladder cancer is one of the most common malignancies of the urinary system and has always presented great challenges in treatment due to its intricate biological features and high recurrence rates. Although great developments were achieved in immunotherapy and targeted therapies within the last dec...
Saved in:
Main Authors: | Peng Huang, Jie Wang, Zongze Yu, Jiaan Lu, Zhou Sun, Zhigui Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1537808/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
by: Mina Cho, et al.
Published: (2024-12-01) -
COMBINED TREATMENT OF LOCALLY-ADVANCED BLADDER CANCER
by: I. V. Chernyshev, et al.
Published: (2016-01-01) -
Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment
by: Kang Liu, et al.
Published: (2025-01-01) -
Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy
by: Shicheng Wang, et al.
Published: (2024-11-01) -
Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer
by: A. V. Troianov, et al.
Published: (2023-03-01)